Product logins

Find logins to all Clarivate products below.


Biosurgical Agents | Market Insights | Japan | 2024

The Japanese biosurgical agent market will exhibit moderate growth over the forecast period. Growth over the forecast period will be driven by continuing growth of procedures in which in biosurgical agents are used, rising awareness of the clinical benefits of these products on surgical outcomes, and the expanded indications in multiple procedures.

This Medtech 360 Report provides comprehensive data and analysis on the state of the biosurgical agent market in Japan from 2019 through 2032.

Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2034, driven by rising demand for MIS procedures among the country’s rapidly aging population. Additionally, the adoption of…
Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Urological Devices – Market Insights – Japan
The Japanese urological device market will continue to expand through 2034, driven by the rising prevalence of risk factors for urological disorders, such as the growing burden of metabolic…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Japan
The Japanese EP mapping and ablation device market will experience moderate growth through 2034, supported by rising cardiac arrhythmia prevalence, broader treatment accessibility, and ongoing…
Report
Sports Medicine Devices – Market Insights – Japan
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, improved surgeon training, and high levels of sports participation will…